Drug Database
N02CC04 rizatriptan
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Maxalt 5mg and 10mg Tablets
- POM Maxalt Melt 10 mg Oral Lyophilisates
- POM Rizatriptan 10 mg orodispersible tablets
- POM Rizatriptan 10 mg Orodispersible Tablets
- POM Rizatriptan 10 mg Orodispersible Tablets
- POM Rizatriptan 10 mg Orodispersible Tablets
- POM Rizatriptan 10 mg tablets
- POM Rizatriptan 10 mg Tablets
- POM Rizatriptan 10mg tablets
- POM Rizatriptan 5 mg Orodispersible Tablets
- POM Rizatriptan 5 mg Tablets
- POM Rizatriptan 5mg tablets
- POM Rizatriptan neuraxpharm 10 mg orodispersible tablets
- POM Rizatriptan Tillomed 10 mg Tablets
- POM Rizatriptan Tillomed 5 mg Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).